Aoki M et al. |
Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor. |
2001 |
J. Pharmacol. Exp. Ther. |
pmid:11504812
|
Thivierge M et al. |
IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. |
2001 |
J. Immunol. |
pmid:11509632
|
Nishimura H et al. |
Acute effects of prostaglandin D2 to induce airflow obstruction and airway microvascular leakage in guinea pigs: role of thromboxane A2 receptors. |
2001 |
Prostaglandins Other Lipid Mediat. |
pmid:11519790
|
Hui Y et al. |
The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization. |
2001 |
J. Biol. Chem. |
pmid:11591709
|
Ro JY et al. |
The inhibitory mechanism of rebamipide on the mediator release in the guinea pig lung mast cells activated with specific antigen-antibody reactions. |
2001 |
Pharmacology |
pmid:11598424
|
Gauvreau GM et al. |
Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma. |
2001 |
Am. J. Respir. Crit. Care Med. |
pmid:11704602
|
Martin V et al. |
Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT(1)) receptors. |
2001 |
Biochem. Pharmacol. |
pmid:11705452
|
Kawagishi Y et al. |
[Clinical significance of measurement of urinary leukotriene E4 in asthmatic patients without attack]. |
2001 |
Arerugi |
pmid:11761885
|
Young RN |
Discovery of montelukast: a once-a-day oral antagonist of leukotriene D4 for the treatment of chronic asthma. |
2001 |
Prog Med Chem |
pmid:11774796
|
Suzuki R and Freed AN |
Heparin inhibits hyperventilation-induced late-phase hyperreactivity in dogs. |
2002 |
Am. J. Respir. Crit. Care Med. |
pmid:11779726
|
Obase Y et al. |
Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. |
2002 |
Chest |
pmid:11796443
|
Kawada N et al. |
The effect of leukotriene D(4) inhalation on the antigen-induced airway hyperresponsiveness and inflammation in 5-lipoxygenase gene-deficient mice. |
2001 |
Int. Arch. Allergy Immunol. |
pmid:11815738
|
Fukuishi N et al. |
Antiallergic effect of ardisiaquinone A, a potent 5-lipoxygenase inhibitor. |
2001 |
Phytomedicine |
pmid:11824521
|
Sakata K and Bäck M |
Receptor preferences of cysteinyl-leukotrienes in the guinea pig lung parenchyma. |
2002 |
Eur. J. Pharmacol. |
pmid:11834255
|
Tada N et al. |
Experimental otitis media with effusion induced by leukotriene D4. |
2002 |
Auris Nasus Larynx |
pmid:11893446
|
Tokuyama K et al. |
Effects of Y-27632, a Rho/Rho kinase inhibitor, on leukotriene D(4)- and histamine-induced airflow obstruction and airway microvascular leakage in guinea pigs in vivo. |
2002 |
Pharmacology |
pmid:11893899
|
Neu IS et al. |
Leukotrienes in patients with clinically active multiple sclerosis. |
2002 |
Acta Neurol. Scand. |
pmid:11903112
|
Lee KH et al. |
Increased expression of endothelial cell adhesion molecules due to mediator release from human foreskin mast cells stimulated by autoantibodies in chronic urticaria sera. |
2002 |
J. Invest. Dermatol. |
pmid:11918713
|
Maekawa A et al. |
Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses. |
2002 |
J. Biol. Chem. |
pmid:11932261
|
Allakhverdi Z et al. |
Inhibition of antigen-induced eosinophilia and airway hyperresponsiveness by antisense oligonucleotides directed against the common beta chain of IL-3, IL-5, GM-CSF receptors in a rat model of allergic asthma. |
2002 |
Am. J. Respir. Crit. Care Med. |
pmid:11934731
|